DavidT.MiyamotoMDPhD
Radiation Oncology • Boston, MAAssociate Professor of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School
Dr. Miyamoto is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Boston, MA 02114Phone+1 617-726-5866Fax+1 617-726-3603
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2007 - 2011- Brigham and Women's HospitalInternship, Internal Medicine, 2006 - 2007
Harvard Medical SchoolClass of 2006
Certifications & Licensure
MA State Medical License 2008 - 2026
ME State Medical License 2020 - 2021- American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- 1119 citationsIsolation of circulating tumor cells using a microvortex-generating herringbone-chipShannon L. Stott, Chia-Hsien Hsu, Dina Tsukrov, Min Yu, David T. Miyamoto
Proceedings of the National Academy of Sciences of the United States of America. 2010-10-26 - 1618 citationsCirculating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer MetastasisNicola Aceto, Aditya Bardia, David T. Miyamoto, Maria C. Donaldson, Ben S. Wittner
Cell. 2014-08-28 - 114 citationsAn RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinomaMark Kalinich, Irun Bhan, Tanya T. Kwan, David T. Miyamoto, Sarah Javaid
Proceedings of the National Academy of Sciences of the United States of America. 2017-01-31
Journal Articles
- A Digital RNA Signature of Circulating Tumor Cells Predicting Early Therapeutic Response in Localized and Metastatic Breast CancerDavid T Miyamoto, Aditya Bardia, Lecia V Sequist, Laura M Spring, Daniel A Haber, Mark Kalinich, Clinical Cancer Research
Press Mentions
MRI-Guided SBRT Shows Sustained Benefits for Prostate CancerOctober 4th, 2024
New Discovery by Massachusetts General Hospital May Help Medical Laboratories Preserve Blood for DNA Analysis, Thus Allowing Isolation of CTCs up to 72 Hours After CollectionJune 27th, 2018
Henning Willers, MD and David Miyamoto, MD, PhD Receive $150,000 Grant from Aid for Cancer ResearchMay 21st, 2018- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
